SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-18-004251
Filing Date
2018-08-22
Accepted
2018-08-22 11:00:39
Documents
66
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q stlt_10q.htm 10-Q 365116
2 CERTIFICATION stlt_ex311.htm EX-31.1 8548
3 CERTIFICATION stlt_ex312.htm EX-31.2 8524
4 CERTIFICATION stlt_ex321.htm EX-32.1 4831
  Complete submission text file 0001477932-18-004251.txt   3964665

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT stlt-20180630.xml EX-101.INS 826112
6 XBRL TAXONOMY EXTENSION SCHEMA stlt-20180630.xsd EX-101.SCH 71568
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE stlt-20180630_cal.xml EX-101.CAL 52365
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE stlt-20180630_def.xml EX-101.DEF 223963
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE stlt-20180630_lab.xml EX-101.LAB 290385
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE stlt-20180630_pre.xml EX-101.PRE 288025
Mailing Address 11147 AURORA AVENUE AURORA BUSINESS PARK, BUILDING 3 URBANDALE IA 50322
Business Address 11147 AURORA AVENUE AURORA BUSINESS PARK, BUILDING 3 URBANDALE IA 50322 515-274-9087
Spotlight Innovation Inc. (Filer) CIK: 0001388486 (see all company filings)

IRS No.: 980518266 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52542 | Film No.: 181031770
SIC: 2834 Pharmaceutical Preparations